biomodal at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
biomodal brings 3 presentations to ISLB 2026 in Madrid. Its work centres on reading genetic, epigenetic and fragment-pattern signals together from cell-free DNA, for cancer detection and minimal residual disease. One study shows that dropping the end-repair step cuts methylation artefacts and improves tumour DNA detection and tissue-of-origin calls.
| Organization | ISLB 2026 Attendance |
|---|---|
biomodal Cambridge, United Kingdom | |
Sequencing chemistry and analysis that read DNA methylation and hydroxymethylation alongside the genetic sequence, applied to cfDNA. |
Instantly find 20 buyers from biomodal
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction